Cerecor competitorsClear all

Cerecor's top competitors include Opiant Pharmaceuticals, Mylan, Amphastar Pharmaceuticals and IntelGenx.
Cerecor
Cerecor
Cerecor is a clinical-stage biopharmaceutical company, which develops drugs to treat patients with neurological and psychiatric disorders.
Opiant Pharmaceuticals
Opiant Pharmaceuticals
Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
Mylan
Mylan
Mylan offers generic and specialty pharmaceutical products.
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals
A specialty pharmaceutical company engaged in the development, manufacturing and marketing of generic and proprietary injectable and inhalation products.
IntelGenx
IntelGenx
IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.
Founding Date
Founding Date
2011
Founding Date
2009
Founding Date
1961
Founding Date
1996
Founding Date
2003
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Baltimore, US HQ
Locations
Santa Monica, US HQ
Locations
Canonsburg, US HQ
Hatfield, GB
Locations
Rancho Cucamonga, US HQ
Locations
Saint-Laurent, CA HQ
Employees
Employees
6468% increase
Employees
1614% increase
Employees
35,000
Employees
2,07826% increase
Employees
3819% increase
Valuation ($)
Valuation ($)
212.9 m
Valuation ($)
51.2 m
Valuation ($)
9.1 b
Valuation ($)
949.3 m
Valuation ($)
50.1 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
9.7 k
Twitter followers
N/A
Twitter followers
1.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
30
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
8.9
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
93.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
593293
Alexa Website Rank
1328923
Alexa Website Rank
295770
Alexa Website Rank
809612
Alexa Website Rank
1102586

Financial

Revenue (est.)
Revenue (est.)
$18.3m (FY, 2018)
Revenue (est.)
$14m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$294.7m (FY, 2018)
Revenue (est.)
$1.8m (FY, 2018)
Cost of goods
Cost of goods
$7.5m (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$187.7m (FY, 2018)
Cost of goods
N/A
Gross profit
Gross profit
$10.8m (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Gross profit
$107m (FY, 2018)
Gross profit
N/A
Net income
Net income
N/A
Net income
($21.2m) (FY, 2018)
Net income
N/A
Net income
($6.7m) (FY, 2018)
Net income
($10.1m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 62m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 1.7m
For sources of this data, please see the company profile

View company profiles

Opiant Pharmaceuticals
HQ
Santa Monica, US
Employees
16↑ 14% increase

Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.

View company
Mylan
HQ
Canonsburg, US
Employees
35,000

Mylan offers generic and specialty pharmaceutical products.

View company
Amphastar Pharmaceuticals
HQ
Rancho Cucamonga, US
Employees
2,078↑ 26% increase

A specialty pharmaceutical company engaged in the development, manufacturing and marketing of generic and proprietary injectable and inhalation products.

View company
IntelGenx
HQ
Saint-Laurent, CA
Employees
38↑ 19% increase

IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.

View company